Status:
UNKNOWN
Anesthetic Efficacy of 1.8 ml Versus 3.6 ml of 4% Articaine Buccal Infiltration
Lead Sponsor:
Cairo University
Conditions:
Symptomatic Irreversible Pulpitis
Eligibility:
All Genders
18-60 years
Phase:
NA
Brief Summary
The aim of the study is to compare the anesthetic efficacy and need for supplemental anesthesia of 1.8 ml compared to 3.6 ml of 4% articaine buccal infiltration in mandibular molars with symptomatic i...
Detailed Description
Patients with moderate-to-severe pain due to symptomatic irreversible pulpitis will be included. Patients will be randomly assigned into two groups to receive either 1.8 ml 4% articaine buccal infiltr...
Eligibility Criteria
Inclusion
- Healthy patients who are categorized as I or II according to The American Society of Anesthesiologists (ASA class I or II).
- No sex predilection
- Patients with symptomatic irreversible pulpitis
- Patient with the ability to understand and use pain scales.
- Patients who accept to enroll in the study.
Exclusion
- Patients' allergies to any of the drugs or materials used in the study.
- Pregnant and lactating females.
- Patients taking analgesics in the last 6-8 hours.
- Patients having more than one symptomatic tooth in the same quadrant
Key Trial Info
Start Date :
December 1 2023
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
June 1 2025
Estimated Enrollment :
70 Patients enrolled
Trial Details
Trial ID
NCT06119139
Start Date
December 1 2023
End Date
June 1 2025
Last Update
November 7 2023
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.